Phase 1 Study of the Novel Proteasome Inhibitor Npi-0052 in Patients with Advanced Malignancies Including Leukemias

P. Padrik, T. J. Price, M. A. Spear, A. Townsend, A. Longenecker, M. A. Palladino, K. G. Lloyd, G. F. Cropp, M. Millward

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

2 Citations (Web of Science)
Original languageEnglish
Pages (from-to)162-162
Number of pages1
JournalAnnals of Oncology
Publication statusPublished - Sept 2008
Event33rd European-Society-for-Medical-Oncology Congress - Stockholm, Sweden
Duration: 12 Sept 200816 Sept 2008

Cite this